Selection and immune recognition of HIV-1 MPER mimotopes

Area of Science:

• Immunology
• Virology
• Vaccine Development

Background:

• The Membrane Proximal External Region (MPER) of HIV-1 gp41 is a critical target for neutralizing antibodies (NAbs).
• Understanding immune responses to MPER is crucial for designing effective HIV vaccines.

Purpose of the Study:

• To identify novel MPER peptide mimotopes.
• To evaluate the reactivity of these mimotopes with antibodies from HIV-infected individuals.
• To characterize the diversity of MPER-specific immune responses during natural HIV infection.

Main Methods:

• Phage display technology was used to generate novel MPER peptide mimotopes.
• Phage immunoprecipitation was employed to map plasma antibody binding profiles from 10 HIV+ patients.
• The reactivity of mimotopes with specific neutralizing antibodies (4E10, 2F5, Z13) was assessed.

Main Results:

• Novel MPER mimotopes were identified, fitting the binding sites of MPER NAbs.
• Patient MPER binding profiles showed unique and overlapping patterns compared to MPER NAbs.
• Binding to 4E10 mimotopes correlated with plasma neutralization of a chimeric virus and overall neutralization breadth/potency.
• Vaccination with 4E10 mimotopes in mice elicited low-titer NAb responses.

Conclusions:

• HIV mimotopes are valuable tools for analyzing plasma antibody specificity.
• The identified mimotopes provide insights into the diversity of immune responses to the MPER region.
• Further research into MPER-targeted immunogens may advance HIV vaccine design.